Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood infection clues: low hemoglobin and frequent sampling may raise PICC risks

NCT ID NCT07674992

Knowledge-focused Sponsor: Mahidol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study examines why some high-risk patients develop central line infections after getting a PICC (a type of long-term IV). Researchers will review medical records from over 1,200 patients to see if low hemoglobin levels or how often blood is drawn from the line play a role. The goal is to identify simple warning signs that could help prevent these serious infections.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If clear risk factors are identified, hospitals could adjust monitoring practices to reduce infections in high-risk patients.
What could go wrong
This is an observational study that can show links but not prove cause and effect. Results may not apply to all hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,239 people

The number who actually took part.

Started

Jan 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Critcally illed patient or patient with cancer who was inserted PICC line

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with PICC line more than 48 hours, performed by Anesthesia Department from January 2023 to December 2024 Exclusion Criteria: * Incomplete data * Patient with reported colonization of PICC line * Patient with unintended position of PICC line * Patient with any other central venous catheter besides PICC line * Patient with previously reported as CLABSI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clabsi - central line associated bloodstream infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Catheter-Related Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clabsi - central line associated bloodstream infection

Contacts and locations

Locations

  • Siriraj Hospital

    Bangkok Noi, Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.